Sarah Rudd, CEO of src | ftbl, discusses applying Moneyball principles to soccer analytics, challenges in implementing data-driven insights in sports, and strategies for valuing players accurately. The podcast explores the complexities of analytics in soccer, innovations in soccer strategies, and the evolution of substitution tactics in matches.

Jimmy Buffi, CEO of Reboot Motion, discusses using computer vision to assist MLB and NBA athletes. Topics include optimizing pitching movements, challenges in basketball shooting techniques, future of computer vision in sports analysis, and predicting human behavior for self-driving cars.

Silvia Blemker, a professor and co-founder of Springbok Analytics, discusses using MRI scans and AI to assist elite athletes and those with muscle diseases. They talk about tailored training plans, muscle health optimization, and injury prevention. The episode explores the challenges of obtaining muscle data and revolutionizing athlete treatment through advanced scanning technology.

Laura Niklason, CEO of Humacyte, discusses creating blood vessels using human cells. Topics include decellularization, synthetic arteries, elastin in vessels, FDA approval, bypass procedures, lab-grown lungs, regenerative medicine tools, and cell intelligence in spare parts creation.

Yasir Arafat, CTO at Aalo Atomics, discusses mass-producing safe, scalable, cheap nuclear reactors for clean energy. Podcast explores history of nuclear power, design considerations, sodium thermal reactor concept, challenges of building micro reactors, research reactors at universities, and techno-economics.

This podcast discusses Justice Sotomayor's potential retirement, sports betting scandals, and Roaring Kitty's return, highlighting the impact on market analysis. It also explores the complexities of employee benefits, enhanced customer experiences, and the integrity of baseball games amidst gambling scandals.

Tim Harford and Jacob Goldstein discuss AI's impact on jobs and universal basic income. They explore automation's effect on human skills and control, investments in cryptocurrency vs. traditional businesses, innovative funding for antibiotics, correlation vs. causation, and enjoying game nights with friends.

Shara Ticku, CEO of C16 Biosciences, discusses creating palm oil alternatives using yeast. They explore microbiology's potential, synthetic biology challenges, and sustainable yeast production. The podcast covers the journey to commercial success and navigating industry regulations.

Rachel Haurwitz, Co-founder and CEO of Caribou Biosciences, discusses using CRISPR to engineer human immune cells to fight cancer. Topics include the journey of CRISPR from breakthrough to FDA approval, enhancing CRISPR's effectiveness, balancing affinity in CRISPR editing, challenges in CAR T-cell therapies for cancer, and reflections on career shifts and gene complexities.

Renowned entrepreneur Robert Langer discusses his journey of co-founding numerous companies and overcoming obstacles in bioengineering. He highlights pioneering work in drug delivery, tissue engineering, and the development of innovative medical technologies. From starting 40 companies to advancing research in neurological diseases, the podcast explores the transformative impact of Langer's groundbreaking innovations.